EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Polymorphisms in the HMGCR Gene and Associations with Cognitive Decline in Parkinson’s Disease Patients

Anna Pierzchlińska iD, Jarosław Sławek, Magdalena Kwaśniak-Butowska, Damian Malinowski iD, Nina Komaniecka iD, Monika Mak, Anna Czerkawska, Arnold Kukowka iD, Monika Białecka

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25168964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anna Pierzchlińska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacokinetics and Therapeutic Drug Monitoring, Pomeranian Medical University, 70-111 Szczecin, Poland. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl CoA Reductases, Parkinson Disease, Polymorphism, Single Nucleotide, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pomeranian Medical University, institutional grants of the Department of Pharmacokinetics and Therapeutic Drug Monitoring, Pomeranian Medical University, Szczecin, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is a common neurodegenerative disease characterized by motor and non-motor symptoms including cognitive impairment and dementia. The etiopathogenesis of PD, as well as its protective and susceptibility factors, are still elusive. 3-Hydroxy-3-methyglutaryl coenzyme A reductase (HMGCR) is an enzyme regulating cholesterol synthesis. Single-nucleotide polymorphisms (SNPs) in the gene coding HMGCR have recently been correlated with the risk of Alzheimer’s disease. Alternative splicing of exon 13 of the HMGCR transcript and its strongly associated HMGCR haplotype 7 (H7: rs17244841, rs3846662, rs17238540) may downregulate protein activity and cholesterol synthesis, with lower low-density lipoprotein cholesterol (LDL) levels associated with PD that may affect cognitive abilities. We genotyped three SNPs in the H7 HMGCR gene in 306 PD patients divided into three groups—without cognitive decline, with mild cognitive impairment (MCI), and with PD dementia—and in 242 healthy participants. A correlation between the rs17238540 genotype and PD susceptibility as well as a minor association between rs3846662 and cognitive status in PD patients was observed; however, the two-sided analysis of these groups did not reveal any significance. We observed a statistically significant elevated high-density lipoprotein cholesterol (HDL) plasma level in the minor allele carriers of rs17238540 and rs17244841 among PD patients. This study should be replicated in a larger population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl CoA ReductasesParkinson DiseasePolymorphism, Single NucleotideCognitive DysfunctionGenetic Predisposition to DiseaseHumansMaleFemaleAgedMiddle AgedHaplotypesGenotypeCase-Control StudiesGenetic Association Studies

Stichwörter der Autor:innen

HMGCRParkinson’s diseasecognitive declinedementiagenetic polymorphismslipids

Substanzen

Hydroxymethylglutaryl CoA ReductasesHMGCR protein, human

Autor:innen und Institutionen

  • Department of Pharmacokinetics and Therapeutic Drug Monitoring, Pomeranian Medical University, 70-111 Szczecin, Poland.
  • Department of Animal Physiology, Institute of Zoology, University of Cologne, 50923 Cologne, Germany.
  • Department of Neurological-Psychiatric Nursing, Faculty of Health Sciences, Medical University of Gdańsk, 80-211 Gdańsk, Poland.
  • Department of Neurology, St Adalbert Hospital, 61-144 Gdańsk, Poland.
  • Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, 70-111 Szczecin, Poland.
  • Department of Health Psychology, Pomeranian Medical University, 70-111 Szczecin, Poland.

ORCID-Profile: Anna Pierzchlińska, Damian Malinowski, Nina Komaniecka, Arnold Kukowka

Förderung

  • Pomeranian Medical University
  • institutional grants of the Department of Pharmacokinetics and Therapeutic Drug Monitoring, Pomeranian Medical University, Szczecin, Poland

Zitieren

APA

Pierzchlińska, A., Sławek, J., Kwaśniak-Butowska, M., Malinowski, D., Komaniecka, N., Mak, M., Czerkawska, A., Kukowka, A., & Białecka, M. (2024). Genetic Polymorphisms in the HMGCR Gene and Associations with Cognitive Decline in Parkinson’s Disease Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168964

Vancouver

Pierzchlińska A, Sławek J, Kwaśniak-Butowska M, Malinowski D, Komaniecka N, Mak M, et al. Genetic Polymorphisms in the HMGCR Gene and Associations with Cognitive Decline in Parkinson’s Disease Patients. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168964

BibTeX
@article{Pierzchliska2024,
  author = {Pierzchlińska, Anna and Sławek, Jarosław and Kwaśniak-Butowska, Magdalena and Malinowski, Damian and Komaniecka, Nina and Mak, Monika and Czerkawska, Anna and Kukowka, Arnold and Białecka, Monika},
  title = {Genetic Polymorphisms in the HMGCR Gene and Associations with Cognitive Decline in Parkinson’s Disease Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25168964}
}
Kostenlos starten →